Search Results - "APOSTOLIDOU, Effie"

Clinical outcomes of patients with newly diagnosed acute myeloid leukemia receiving treatment in a safety-net hospital system by Lu, Jason, Bhakta, Preeya, Lachowiez, Curtis Andrew, Apostolidou, Effie

“…7035 Background: Standard induction therapy for acute myeloid leukemia (AML) results in 5-year overall survival (OS) rates of 30-45%. Further risk…”
Get full text

Unusual association between increased bone resorption and presence of paroxysmal nocturnal hemoglobinuria phenotype in multiple myeloma by TERPOS, Evangelos, SAMARKOS, Michalis, MELETIS, Christos, APOSTOLIDOU, Effie, TSIRONI, Maria, KOROVESIS, Konstantinos, MAVROGIANNI, Despina, VINIOU, Nora, MELETIS, John

“…Paroxysmal nocturnal hemoglobinuria (PNH) clones deficient in glycosylphosphatidylinositol-anchored molecules, including CD55 and CD59, have been previously…”
Get full text

Detection of CD55- and/or CD59-deficient red cell populations in patients with plasma cell dyscrasias by MELETIS, John, TERPOS, Evangelos, VARIAMI, Eleni, VINIOU, Nora, KONSTANTOPOULOS, Konstantinos, SAMARKOS, Michalis, MELETIS, Christos, APOSTOLIDOU, Effie, KOMNINAKA, Veroniki, KOROVESIS, Konstantinos, ANARGYROU, Konstantinos, BENOPOULOU, Olga, MAVROGIANNI, Despina

“…Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal disorder characterized by a decrease or absence of glycosylphosphatidylinositol (GPI)-anchored…”
Get full text

Red cells with paroxysmal nocturnal hemoglobinuria-phenotype in patients with acute leukemia by Meletis, John, Terpos, Evangelos, Samarkos, Michalis, Meletis, Christos, Apostolidou, Effie, Komninaka, Veroniki, Anargyrou, Konstantinos, Korovesis, Konstantinos, Mavrogianni, Despina, Variami, Eleni, Viniou, Nora, Konstantopoulos, Konstantinos

“…CD55 and CD59 are complement regulatory proteins that are linked to the cell membrane via a glycosyl-phosphatidylinositol anchor. They are reduced mainly in…”
Get more information

Detection of CD55 and/or CD59 deficient red cell populations in patients with aplastic anaemia, myelodysplastic syndromes and myeloproliferative disorders by Meletis, J, Terpos, E, Samarkos, M, Meletis, C, Konstantopoulos, K, Komninaka, V, Apostolidou, E, Benopoulou, O, Korovesis, K, Mavrogianni, D, Variami, E, Yataganas, X, Loukopoulos, D

“…Paroxysmal nocturnal haemoglobinuria (PNH) is an acquired clonal stem cell disorder characterized by intravascular haemolysis, venous thrombosis, marrow…”
Get more information

Detection of CD55- and/or CD59-deficient red cell populations in patients with lymphoproliferative syndromes by Meletis, J, Terpos, E, Samarkos, M, Meletis, C, Apostolidou, E, Komninaka, V, Korovesis, K, Mavrogianni, D, Boutsis, D, Variami, E, Viniou, N, Konstantopoulos, K, Loukopoulos, D

“…Paroxysmal nocturnal hemoglobinuria is an acquired clonal stem cell disorder characterized by the decrease or absence of glycosylphosphatidylinositol-anchored…”
Get more information